Characterisation of HBV DNA in reference preparations

Slides:



Advertisements
Similar presentations
Replacement of the 1 st Parvovirus B19 DNA International Standard SoGAT XXI, Brussels, 28th-29th May 2009 Sally Baylis.
Advertisements

Proposal to Prepare Reference Panels & Standards for Hepatitis E Virus
XX. SoGAT Meeting Warsaw 12./13. June 2007 IU vs. NAT-Detectable Units Albrecht Gröner CSL Behring Virology Marburg, Germany.
Jean-Michel PAWLOTSKY
HBsAg+ candidate blood donors HBV genotypes Number Origin(s) A1 43 S. Africa A2 72 Poland B 126 Hong Kong Malaysia Taiwan Thailand C 90 Hong Kong Malaysia.
The Sense of Sensitivity I Dr. Matthias Gessner Plasma Control Europe/Plasma Analytics Baxter AG, Vienna.
Karen Cristiano Biologicals Unit, CRIVIB Calibration against the WHO Standards of National Reference Preparations for detection of blood viruses by NAT:
PROFICIENCY TESTING OF IN-HOUSE NAT ASSAYS USED FOR BLOOD SCREENING XXI SoGAT International Working Group Meeting on the Standardization of NAT for the.
Limitations of HBsAg testing in the screening of blood donors Wolfram H. Gerlich Institute of Medical Virology University Giessen, Germany SoGAT XVI Langen.
ICBS Master Panels for Kit Evaluation: HCV, HBV, and HIV ( Howard A. Fields, Ph.D. Susan Diaz, MPH Division of Viral Hepatitis Centers.
BioLife Plasma Services Experience with HBV NAT Testing
1 HBV Genotype Panel Michael Chudy Section of Molecular Virolgy Division of Virology SoGAT XXI Meeting Brussels, May 2009.
Michael Chudy, Paul-Ehrlich-Institut SoGAT XVIII, Bethesda MD
CE MARKING OF IVDDs - the NIBSC perspective Morag Ferguson Division of Virology.
EQASs for Blood Borne Virus Genomes and BSE Prions from Cattle Brain and INSTAND Reference Materials H.-P. Grunert 1,2, K.-O. Habermehl 1,2, V. Lindig.
Establishment of the 1st WHO International Standard for Detection of Antibodies to Hepatitis B Virus Core Antigen (anti-HBc) SoGAT XXI 29 May 2009 Dr.
Stability of HCV, HIV-1 and HBV nucleic acids in plasma samples stored at different temperatures Marta José, Rodrigo Gajardo and Juan I. Jorquera Instituto.
Yi-Chen Yang, Yu-Hsuan Chen, Show-Lan Chiu, Hwei-Fang Cheng Drug Biology Division, Bureau of Food and Drug Analysis Department of Health, Taiwan, ROC National.
SoGAT XVII/Paris, 2004 Proficiency Testing of In-House Developed HIV-1 NAT for Blood Screening Michael Chudy, Paul-Ehrlich-Institut Division of Virology,
B19 inactivation by heat treatment with epithelial cell lines Yoshiaki Okada Kiyoko Umemori Kazunari Yamaguchi National Institute of Infectious Disease.
SoGAT June 14, 2006 HCV-RNA and HIV-RNA detection in small test pools of cadaveric samples for viral safety of tissue transplants Maarten Koot#,
Active B19 virions production in hepatoblastoma and hepatocarcinoma cell lines: amplification and genomic stability. Op de beeck A. 1, Draps M.-L. 1, Baurin.
Update on the P. falciparum Standard & Replacement of the HBV & HCV International Standards Sally Baylis, NIBSC SoGAT XIX.
A multi-centre NAT evaluation study of run and trend control samples Harry van Drimmelen 1, Joe O’Donnellan 2, Rene Bax 1, Henrik Ullum 3 and the Danish.
NUCLEIC ACID AMPLIFICATION TECHNOLOGY HCV-RNA / HBV-DNA / HIV-RNA testing blood and blood components for transfusion Italian External Quality Assessment.
International Scientific Workshop on the Standardization of Genome Amplification Techniques for the Safety Testing of Blood, Tissues and Organs With Regard.
SoGAT 2005 Donor screening for parvovirus B19 antibodies: Reducing or eliminating the risk of transmission SoGAT 2005 Gordon Elliott Biotrin 93 The Rise.
Preparation of HBV DNA reference standards and the experience of HBV NAT in Taiwan Dr. Hwei-Fang Cheng Department of Health, Taiwan.
An Overall View of Standardization May 26, 2004 Indira Hewlett, Ph.D. CBER/FDA.
Novel and Related Variant Parvoviruses in Human Plasma Jacqueline Fryer and Sally Baylis National Institute for Biological Standards and Control Eric Delwart.
DRK-Blutspendedienst West  nPrecipitation steps (PEG), centrifugation and careful resuspension of the invisible pelleted viral particles precede efficient.
DRK-BSD NSTOB & West 19th SoGAT Meeting, 14/15 June 2006, Bern Experience with Roche´s COBAS AmpliPrep/COBAS TaqMan96 automated PCR system in two large.
SoGAT May 2005 Are conversion factors to international units assay related? Marco Koppelman, Henk Reesink, Nico Lelie, Theo Cuypers.
SOGAT Presence (absence) of genotype 2 and 3 Erythrovirus DNA in manufacturing plasma Theo Cuypers, Marco Koppelman, Margret Sjerps, Henk Reesink.
Sean Doyle National University of Ireland, Maynooth, Ireland. Parvovirus B19 Infection in Seronegative and Seropositive Individuals – Implications for.
Response to Comment on "Inhibition of Hepatitis B Virus Replication by APOBEC3G" by Priscilla Turelli, Stéphanie Jost, Bastien Mangeat, and Didier Trono.
A logcopies/ml b IU/ml HBV DNA levels ALT levels Figure S1.
A.Professor Gehan Lotfy abdel Hakeem Minia University Egypt
Saeko Mizusawa, Yoshiaki Okada
Sixth Workshop of National Reference Laboratories for Parasites
In The Name of God.
GRIFOLS PLASMA: genotype 2 vB19 sample
Harvey Holmes, Clare Morris and Neil Berry Division of Retrovirology
Preparation of plasmids containing HBV-full genome of genotype A to H and trial of HBV inactivation method Yoshiaki Okada Kiyoko Umemori Kazunari.
by Mark T. Boyd, Brian Foley, and Isadore Brodsky
Volume 42, Issue 6, Pages (June 2005)
Volume 65, Issue 4, Pages (October 2016)
Update on WHO Projects.
Unit 13: Solutions & Equilibrium
Evaluation of Candidate Standard XX (97/650)
Solutions Section 3: Dilutions Dilutions Calculations print 1-3,5-7.
Volume 123, Issue 6, Pages (December 2002)
Feasibility of Synthetic Materials as Primary Standards
Italian EQA study for HCV RNA, HIV RNA and HBV DNA G. M. Bisso, K
1st International Standard for HIV-1 RNA NIBSC Code 97/656
Distributions of parvovirus B19 genotype 1-3 in blood donations
Volume 37, Issue 1, Pages 2-6 (July 2002)
SoGAT Meeting, Berne, 14 June 2006 M. Nübling (PEI, Germany)
Unit 13: Solutions & Equilibrium
RESEARCH ON THE PRODUCTION OF HBsAg STANDARD SERUM FOR QUALITY CONTROL
Comparison of a commercial and ‘in house’ assay for B19 DNA
Impact of New Hepatitis C Treatments in Different Regions of the World
Hepatitis E virus as a newly identified cause of acute viral hepatitis during human immunodeficiency virus infection  P. Colson, C. Dhiver, R. Gérolami 
Hepatitis B core-related antigen (HBcrAg) levels in the natural history of hepatitis B virus infection in a large European cohort predominantly infected.
SoGAT meeting XXI May (2009), Brussels, Belgium
H. Leblebicioglu, C. Eroglu  Clinical Microbiology and Infection 
Hepatitis C Genotypes: Current Trends and Future Implications
Volume 56, Issue 3, Pages (March 2012)
ANALYTICAL CONTROL SYSTEM AS A MEASURE TO ENSURE INFECTIOUS SAFETY OF HUMAN PLASMA FOR FRACTIONATION A.L. Poptsov FSBI “ROSPLASMA” RMSPC of FMBA of RUSSIA.
Presentation transcript:

Characterisation of HBV DNA in reference preparations SoGAT XXI, Brussels May 29, 2009 Characterisation of HBV DNA in reference preparations Corinna Bremer, Dieter Glebe, Wolfram H. Gerlich Institute for Medical Virology (IMV), Justus Liebig University Giessen, Germany National Consulting laboratory for Hepatitis B und D Nico Lelie Chiron Novartis Vaccines and diagnostics, Suresnes France

Characterisation of HBV DNA in reference preparations SoGAT XXI, Brussels May 29, 2009 Characterisation of HBV DNA in reference preparations Methods described in: Corinna Bremer et al., Transfusion, 2009

Origin of Reference Materials for HBV DNA WHO: dilution of Eurohep standard reference 1, genotype A2, HBs subtype adw, lyophilised 5 x 105 IU disolved in 0.5 ml H2O  5 x106 ge/ml VQC : 3 x 108/9 ge/ml (1997 Sanquin) lower in our PCR  2 x 108 ge/ml genotype A2 VQC pasteurized: 1.2 x 107 ge/ml 1:100 dilution of VQC ISS genotype D: 7,500 IU/ml  3.75 x 104 ge/ml ISS = Istitute Superiore di Sanità Conversion factor IU to ge = 5

Digestion of free cloned or virus encapsidated HBV DNA 200 µl serum, 500 Units DNAse (Benzonase), 1 h 37°C, real-time PCR of X-region 89% 115% 81% 0.01% 1% <0.1%

Sucrose gradient centrifugation of reference samples for HBV particles SW 41, 25,000 rpm, 16h, 10°C, fractions of 0.5 ml, Inhouse real-time PCR of the X-region % sucrose volume Reference sample 0.2 ml 5 1 ml 10 1.5 ml 20 30 40 2 ml 50 60 60+10% KBr

Banding of HBV DNA together HBV particles 25,000 rpm, 16h, 10°C

Conclusion All analysed reference samples contained HBV DNA in virus- associated form